Immunohistochemical localization of telomerase in myomas and in uterine myometrium

Pathology Research and Practice

Volumn 204, Issue 9, 2008, Pages 637-642

  Madej, Paweł ^a   Plewka, Andrzej ^a   Madej, Janusz A ^b   Dzimira, Stanisław ^b   Nowak, Marcin ^b   Plewka, Danuta ^a   Nowaczyk, Grazyna ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b Department of Pathological Anatomy   (Poland)

Author keywords

Conservative treatment; Myomas; Neoplasia; Telomerase; Uterus

Indexed keywords

TELOMERASE;

ADULT; ARTICLE; CANCER CELL; CELL ASSAY; CLINICAL ARTICLE; CONSERVATIVE TREATMENT; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE MARKER; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MUSCLE CELL; MYOMA; MYOMETRIUM; PROTEIN CONTENT; PROTEIN LOCALIZATION; SAMPLING; UTERUS TUMOR;

ADULT; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LEIOMYOMA; MIDDLE AGED; MYOMETRIUM; TELOMERASE; TUMOR MARKERS, BIOLOGICAL; UTERINE NEOPLASMS;

EID: 49749117448     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2008.02.006     Document Type: Article

References (31)

1. Blackburn E.H. Telomere states and cell fates. Nature 408 (2000) 53-56
2. Blasco M.A. Telomeres and human disease: ageing, cancer and beyond. Nat. Rev. Genet. 6 (2005) 611-622
3. Bodnar A.G., Ouellette M., Frolkis M., Holt S.E., Chiu C.P., Morin G.B., Harley C.B., Shay J.W., Lichtsteiner S., and Wright W.E. Extension of life-span by introduction of telomerase into normal human cells. Science 279 (1998) 349-352
4. Carney S.A., Tahara H., Swartz C.D., Risinger J.I., He H., Moore A.B., Haseman J.K., Barrett J.C., and Dixon D. Immortalization of human uterine leiomyoma and myometrial cell lines after induction of telomerase activity: molecular and phenotypic characteristics. Lab. Invest. 82 (2002) 719-728
5. Chen K.Y., Lee L.N., Yu C.J., Lee Y.C., and Kio S.H. Elevation of telomerase activity positively correlates to poor prognosis with non-small cell lung cancer. Cancer Lett. 240 (2006) 148-156
6. Condon J., Yin S., Mayhew B., Word R.A., Wright W.E., Shav J.W., and Rainev W.E. Telomerase immortalization of human myometrial cells. Biol. Reprod. 67 (2002) 506-514
7. Gelmini S., Crisci A., Salvadori B., Pazzagli M., Selli C., and Orlando C. Comparison of telomerase activity in bladder carcinoma and exfoliated cells collected in urine and bladder washings, using a quantitative assay. Clin. Cancer Res. 6 (2000) 2771-2776
8. Gurwitz D. Telomerase expression and cancer: a controversy finally put to rest?. Clin. Genet. 55 (1999) 306-308
9. Hayashidini Y., Hiyama E., Murakami Y., and Seuda T. Attenuation of telomerase activity by hammerhead ribozymes targeting humam telomerase RNA and telomerase reverse transcriptase in pancreatic carcinoma cells. Hiroshima J. Med. Sci. 1 (2005) 21-27
10. Heaphy C.M., Bisoffi M., Fordyce C.A., Haaland C.M., Hines W.C., Joste N.E., and Griffith J.K. Telomere DNA content and allelic imbalance demonstrate field cancerization in histologically normal tissue adjacent to breast tumors. Int. J. Cancer 119 (2006) 108-116
11. Ito Y., Yoshida H., Tomoda C., Uruno T., Takamura T., Miva A., Kobayashi K., Matsuzuka F., Kuma K., and Mivauchi A. Telomerase activity in thyroid neoplasms evaluated by the expression of human telomerase reverse transcriptase (hTERT). Anticancer Res. 25 (2005) 509-514
12. Jiang X.R., Jimenez G., Chang E., Frolkis M., Kusler B., Sage M., Beeche M., Bodnar A.G., Wahl G.M., Tlsty T.D., and Chiu C.P. Telomerase expression in human somatic cells does not induce changes associated with a transformed phenotype. Nat. Genet. 21 (1999) 111-114
13. Klapper W., Krams M., Qian W., Janssen D., and Parwaresch R. Telomerase activity in B-cell non-Hodgkin lymphomas is regulated by hTERT transcription and correlated with telomere-binding protein expression but uncoupled from proliferation. Br. J. Cancer 89 (2003) 713-719
14. MacNamara B., Wang W., Chen Z., Hou M., Mazur J., Gruber A., and Porwit-MacDonald A. Telomerase activity in relation to pro- and anti-apoptic protein expression in high grade non-Hodgkin's lymphomas. Haematologica 86 (2001) 386-393
15. Menson M.M., and Simha M.R. Telomerase and telomere lenght in normal and malignant human endometrium as prognostic markers. Int. Pathol. Microbiol. 46 (2003) 394-398
16. Mera S.L. The role of telomeres in ageing and cancer. Br. J. Biomed. Sci. 55 (1998) 221-225
17. Nagai N., Oshita T., Murakami J., and Ohama K. Semiquantitative analysis of telomerase activity in cervical cancer and precancerous lesions. Oncol. Rep. 6 (1999) 325-328
18. Neves M., Ciofu C., Larousserie F., Fleury J., Sibony M., Flahault A., Soubrier F., and Gattegno B. Prospective evaluation of genetic abnormalities and telomerase expression in exfoliated urinary cells for bladder cancer detection. J. Urol. 167 (2002) 1276-1281
19. Norrback F., Hultdin M., Dahlenborg K., Osterman P., Carlsson R., and Roos G. Telomerase regulation and telomere dynamics in germinal centers. Eur. J. Haematol. 67 (2001) 309-317
20. Parris C.N., Jezzard S., Silver A., MacKie R., McGregor J.M., and Newbold R.F. Telomerase activity in melanoma and non-melanoma skin cancer. Br. J. Cancer 79 (1999) 47-53
21. Sakamoto M., Toyoizumi T., Kikuchi Y., Okamoto A., Nakayama H., Aoki D., Yamamoto K., Hata H., Sugishita T., and Tenjin Y. Telomerase activity in gynecological tumors. Oncol. Rep. 7 (2000) 1003-1009
22. Sakurai S., Fukayama M., Kaizaki Y., Saito K., Kanazawa K., Kitamura M., Iwasaki Y., Hishima T., Hayashi Y., and Koike M. Telomerase activity in gastrointestinal stromal tumors. Cancer 83 (1998) 2060-2066
23. Shay J.W., and Bacchetti S. A survey of telomerase activity in human cancer. Eur. J. Cancer 33 (1997) 787-791
24. de Souza Nascimento P., Alves G., and Fiedler W. Telomerase inhibition by an siRNA directed against hTERT leads attrition in HT29 cells. Oncol. Rep. 16 (2006) 423-428
25. Tahara H., Kuniyasu H., Yokozaki H., Yasui W., Shay J.W., Ide T., and Tahara E. Telomerase activity in preneoplastic and neoplastic gastric and colorectal lesions. Clin. Cancer Res. 1 (1995) 1245-1251
26. Ulaner G.A., Hu J.F., Vu T.H., Oruganti H., Giudice L.C., and Hoffman A.R. Regulation of telomerase by alternate splicing of human telomerase reverse transcriptase (hTERT) in normal and neoplastic ovary, endometrium and myometrium. Int. J. Cancer 85 (2000) 330-335
27. Unate H., Ikeguchi M., Kaibara N., Okamura D., Nishihara S., Katoh M., and Oshimura M. Telomerase activity and microsatellite instability in colorectal cancer and adenoma. Int. J. Oncol. 13 (1998) 1223-1228
28. Vasef M.A., Ross J.S., and Cohen M.B. Telomerase activity in human solid tumors. Diagnostic utility and clinical applications. Am. J. Clin. Pathol. 112 Suppl. 1 (1999) S68-S75
29. Yokoyama Y., Takahashi Y., Shinohara A., Lian Z., and Tamaya T. Telomerase activity in the female reproductive tract and neoplasms. Gynecol. Oncol. 68 (1998) 145-149
30. Zasławski R., Surowiak P., Dziegiel P., Pretnik L., and Zabel M. Analysis of the expression of estrogen and progesteron receptors, and of PCNA and Ki67 proliferation antigens, in uterine myomata cells in relation to the phase of the menstrual cycle. Med. Sci. Monit. 7 (2001) 908-913
31. Zheng J.N., Sun Y.F., Pei D.S., Liu J.J., Chen J.C., Li W., Sun X.Q., Shi Q.D., Han R.F., and Ma T.X. Inhibition of proliferation and induction of apoptosis in human renal carcinoma cells by anti-telomerase small interfering RNAs. Acta Biochim. Biophys. Sin. (Shanghai) 38 (2006) 500-506